drugset / Trial / NCT00828659

Abuse Potential of Single Doses of Lorcaserin in Healthy Recreational Polydrug Users

NCT00828659

Phase 1 Completed 35 enrolled Eisai Inc.
RandomizedCrossoverDouble-blindOther

Summary

The purpose of this study is to evaluate the abuse potential of lorcaserin in healthy recreational polydrug users.

Timeline

Start
2008-12
Primary completion
2009-04
Completion
2009-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ketamine Small molecule 100 mg Oral
Subject Lorcaserin Small molecule 20 mg Oral
Subject Lorcaserin Small molecule 40 mg Oral
Subject Lorcaserin Small molecule 60 mg Oral
Comparator Zolpidem Small molecule 15 mg Oral
Comparator Zolpidem Small molecule 30 mg Oral

Indications